Searched for
JAPANS DAIICHI
Daiichi Sankyo, Merck ink $22-billion cancer drug dealThe deal adds promising drug candidates to Merck's oncology portfolio, as its bestselling cancer therapy Keytruda will see its patent expir...20 Oct, 2023, 11.50 PM IST- Bank of India looks to divest insurance JV stake for $160 millionBoI is looking to sell 64.9 million shares, or 25.02 per cent stake, in Star Union Dai-ichi Life Insurance Co.05 Apr, 2019, 01.38 PM IST
- Ranbaxy Laboratories to market Daiichi Sankyo's Sevikarin in RomaniaRanbaxy Labs will market Daiichi Sankyo's antihypertensive drug Sevikarin in Romania expanding its hybrid model strategy to the European co...19 Apr, 2012, 02.38 PM IST
- Ranbaxy laboratories may hand over Latin American operations to Daiichi SankyoRanbaxy may hand over its L American mkting operations to Daiichi Sankyo, a move could be a precursor to the Indian drugmaker's exit from s...25 Feb, 2012, 08.30 AM IST
- Star Union Dai-Ichi targets 1,700 cr premium this fiscalStar Union Dai-Ichi Life Insurance Company is a joint venture of Bank of India, Union Bank of India and Dai-ichi Life Insurance, Japan.03 Jan, 2012, 03.22 PM IST
- Ranbaxy to sell Daiichi Sankyo product in MalaysiaDrug firm Ranbaxy Laboratories and Japan's Daiichi Sankyo today said Ranbaxy will market its parent company's products in Malaysia.21 Dec, 2011, 03.03 PM IST
- US asks its citizens to defer any travel to Japan"The State Department strongly urges US citizens to defer travel to Japan at this time and those in Japan should consider departing," State...19 Mar, 2011, 11.04 AM IST
- Daiichi's own man to head Ranbaxy qualityJapan's Daiichi Sankyo has named an executive with more than 25 years of experience to oversee the quality and manufacturing standards in R...17 May, 2010, 06.37 AM IST
- Daiichi sets up firm to market Ranbaxy products in JapanRanbaxy’s Japanese parent Daiichi Sankyo has set up a new firm, Daiichi Sankyo Espha Company (DSECL) for marketing generic drugs in Japan.11 May, 2010, 08.19 PM IST
- Daiichi sees $3.9 bn loss on Ranbaxy buyJapan's Daiichi Sankyo, the new owner of India's largest drugmaker Ranbaxy Laboratories expects a non-cash valuation loss of $3.9 billion o...05 Jan, 2009, 07.22 PM IST
- Daiichi Life plans Japan’s biggest IPO in decadeDaiichi Mutual Life Insurance hired Nomura Holdings, Merrill Lynch and Mizuho Financial Group to sell its shares in Japan’s biggest initial...26 Dec, 2008, 12.55 AM IST
- Ranbaxy to acquire more firms despite change in ownershipRanbaxy, in which Japan's Daiichi Sankyo will acquire the majority stake, has said it would continue to pursue acquisitions. Ranbaxy sell-o...21 Jun, 2008, 11.30 AM IST
- Ranbaxy dismisses reports of Pfizer's bid for stakeJoining forces with Daiichi strengthens Ranbaxy's fledging and expensive efforts to develop original drugs, said CEO Malvinder Singh. Ranba...16 Jun, 2008, 10.00 PM IST
- Malvinder Singh defends his "emotional" decision to sell RanbaxyRanbaxy CEO Malvinder Mohan Singh has been flooded with messages from friends who are still sceptical about his decision. Ranbaxy sell-off16 Jun, 2008, 04.47 PM IST
- Govt to seek room for drug firms in JapanEndorsing the Daiichi-Ranbaxy deal, the Indian government is planning to make the most of it in its bilateral trade and investment pact bei...14 Jun, 2008, 12.13 AM IST
- Ranbaxy sees bright future in ageing JapanThe head of India's generic drug leader Ranbaxy sees a bright future in Japan as its population gets older.12 Jun, 2008, 05.45 PM IST
- What does Daiichi bring for Ranbaxy investors?While Ranbaxy is slated to become a subsidiary of Japan’s third largest pharma company, Daiichi Sankyo, Ranbaxy’s investors may have to wai...12 Jun, 2008, 01.56 AM IST
Load More
